Evaluation of prospective urinary protein biomarkes in the early detection of soft tissue sarcoma/ osteosarcoma

Recruiting

• Conditions: C41; C49; Malignant neoplasm of bone and articular cartilage of other and unspecified sites; Malignant neoplasm of other connective and soft tissue

• Registration Number: DRKS00021209
• Lead Sponsor: Medizinische Hochschule Hannover

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-04-20
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

Patients with suspected malignant musculoskeletal tumor.

Exclusion Criteria

Pregnancy. Nursing period. Benign musculoskeletal tumor.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary endpoint of the study is to characterize urinary proteom patterns which are associated with different entities of musculoskeletal tumors at the time of primary diagnosis.

Secondary Outcome Measures

Name	Time	Method
o secondary endpoint. This study will be used as a pretrial to evaluate the necessary sample size.